Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections
Stopped Difficulties encountered in the recruitment process and slow enrollment. The study was not terminated due to any safety issues or concerns.
Conditions
- Carbapenem-Resistant Enterobacteriaceae Infection
Interventions
- DRUG: Ceftazidime-avibactam
- DRUG: Colistin
Sponsor
King Faisal Specialist Hospital & Research Center